JPRN-C000000357已完成1 期
Evaluation of the safety and efficacy of allogenic hematopoietic stem cell transplantation (HSCT) from HLA-mismatched related donors using alemtuzumab in patients with hematological malignancies. - HLA-mismatched HSCT using alemtuzumab
GCP-ISS HE0402 group0 个研究点目标入组 48 人开始时间: 2006年3月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Adult T cell leukemia/lymphoma (2)Diabetes uncontrollable even with regular insulin use. (3)Uncontrollable hypertension. (4)Active infection. (5)Refractory hematological malignancies with bone marrow involvement more than 30% of tumor cells. (6)Active central nervous system involvement. (7)Current active double cancer. (8)Women who are or may be pregnant, or who are nursing. (9)Uncontrollable mental illness. (10)Hepatitis B virus antigen-positive (HBsAg or HBeAg). (11)HIV-positive. (12)A history of hypersensitivity to transplant conditioning agents (fludarabine phosphate, busulfan, cyclophosphamide) or agents for GVHD prophylaxis (ciclosporin, methotrexate). (13)A history of hematopoietic stem cell transplantation. However, a single prior autologous transplantation is permitted.
研究者
相似试验
招募中
1 期
Evaluation of the safety and efficacy of allogeneic activated Natural killer cells in metastatic Colon AdenocarcinomaIRCT20230704058675N1Middle East Gene Therapy corporation10
已完成
1 期
Evaluation of the safety and efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) using alemtuzumab for patients with aplastic anemiaAplastic anemiaJPRN-C000000356GCP-ISS HE0403 group38
尚未招募
1 期
Assessment of the effect of allogeneic adipose derived mesenchymal stem cells along with platelet rich fibrin for perianal fistulas in treatment of perianal fistulasperianal fistula.Fistula, other specified siteM25.18IRCT20210830052332N1Iranian academic center for education culture and research24
招募中
1 期
Application of Cord Blood Platelet Gel (CBPG) for the treatment of non-healing skin ulcers due to the cutaneous chronic GVHDIRCT20190101042197N1Royan Stem cell Technology Co.15
招募中
1 期
Effect of NK cell therapy in COVID-19IRCT20200417047113N1Middle East Gene Therapy corporation70
